What is the ROE (Return on Equity) of Healios KK this year?
The ROE of Healios KK this year is -0.99 undefined.
Healios KK ROE 2024
Healios KK ROE
-0.99
Ticker
4593.T
ISIN
JP3835100003
WKN
A14U80
In 2024, Healios KK's return on equity (ROE) was -0.99, a -15.93% increase from the -1.18 ROE in the previous year.
Healios KK Aktienanalyse
What does Healios KK do?
Healios KK is a Japanese company founded in 2011. It focuses on the development of neuroscience, particularly the treatment of central nervous system disorders. Healios KK is headquartered in Tokyo and currently employs approximately 100 employees. Business Model: Healios KK aims to develop and market innovative treatments for patients with neurological disorders. The company works closely with research institutes, universities, and other companies to make progress in the development of new drugs and therapies. Healios KK is also involved in clinical research and works to translate its research findings into new products. Divisions: The company focuses on four main areas: - Regenerative Medicine - Stem Cell Therapy - Brain-Computer Interfaces - AI-supported Diagnosis Regenerative Medicine: Healios KK researches new technologies for the treatment of neurological disorders through regenerative medicine, particularly through stem cell therapy. The company collaborates closely with researchers to develop groundbreaking technologies that support the healing of nerve cells and promote brain regeneration. Stem Cell Therapy: Healios KK also focuses on stem cell therapy, which is being investigated in the company's research labs to find new treatment options for patients with spinal injuries, strokes, Parkinson's, and other neurological disorders. Stem cell therapy involves using stem cells to regenerate damaged tissue in the brain or spinal cord. Brain-Computer Interfaces: Healios KK is also working on the development of brain-computer interfaces (BCIs) that aim to establish a direct connection between the brain and a computer. With the help of these interfaces, patients with paralysis or certain neurological disorders can regain control over their movements and activities. Healios KK has developed a smartglove that can be controlled using BCI. AI-supported Diagnosis: Using state-of-the-art artificial intelligence (AI) technologies, Healios KK is developing new and more effective diagnostic methods for neurological disorders. By developing algorithms based on brain scan images, AI-supported diagnoses are expected to be faster and more effective in the future. Products: Healios KK offers a wide range of products and therapies to effectively treat patients with neurological disorders. These include: - Stem Cell Therapy: The company develops and distributes stem cell therapies to treat patients with spinal injuries, strokes, and other neurological disorders. - Smartglove: Healios KK has developed an intelligent glove that is controlled through brain-computer interfaces. The glove is intended for patients who are unable to move their hands due to paralysis. - AI-supported Diagnosis: The company is working on computer-assisted diagnoses of neurological disorders that are more effective and accurate than conventional diagnoses. - Clinical Trials: Healios KK also conducts clinical trials to investigate the effectiveness of new therapies and treatment methods. Summary: Healios KK is a Japanese company focused on developing innovative therapies and treatment methods for neurological disorders. The company works closely with research institutes and other companies to make progress in the development of new drugs and therapies. Healios KK has four main divisions: Regenerative Medicine, Stem Cell Therapy, Brain-Computer Interfaces, and AI-supported Diagnosis. The company offers a variety of products, including stem cell therapy, smartgloves, and AI-supported diagnoses. Healios KK aims to enhance the lives of patients with neurological disorders by using innovative technologies to support their health. Healios KK ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Healios KK's Return on Equity (ROE)
Healios KK's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Healios KK's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Healios KK's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Healios KK’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Healios KK stock
How has the Return on Equity (ROE) of Healios KK developed compared to the previous year?
The ROE of Healios KK has increased by -15.93% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Healios KK?
A high ROE indicates that Healios KK generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Healios KK?
A low ROE can indicate that Healios KK is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Healios KK affect the company?
A change in ROE (Return on Equity) of Healios KK can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Healios KK?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Healios KK?
Some factors that can influence Healios KK's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Healios KK pay?
Over the past 12 months, Healios KK paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Healios KK is expected to pay a dividend of 0 JPY.
What is the dividend yield of Healios KK?
The current dividend yield of Healios KK is .
When does Healios KK pay dividends?
Healios KK pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Healios KK?
Healios KK paid dividends every year for the past 0 years.
What is the dividend of Healios KK?
For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.
In which sector is Healios KK located?
Healios KK is assigned to the 'Health' sector.
Wann musste ich die Aktien von Healios KK kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Healios KK from 8/14/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 8/14/2024.
When did Healios KK pay the last dividend?
The last dividend was paid out on 8/14/2024.
What was the dividend of Healios KK in the year 2023?
In the year 2023, Healios KK distributed 0 JPY as dividends.
In which currency does Healios KK pay out the dividend?
The dividends of Healios KK are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Healios KK
Our stock analysis for Healios KK Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Healios KK Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
